Rongelap 40
NAME
HOSPITAL OF THE MEDICAL RESEARCH CENTER,
QROOKHAVEN MATIONAL LABORATORY
UPTON, NEW YORK 11973
08-45-42R
Ares Code 516 YAphank 446262
{UNIT NO.)
DISCHARGE SUMMARY
time of discharge on June 10th, he was symptom free and his thyroid of normal size.
ae
“
,
.
AT the Metropolitan General
Hospital thyroid surgery was performed by
tos
ae
"
The
-
cause of this episode is unclear.
—_—-—
HOSPITALCOURSECONTINUED :
=
Dr. Brown Dobyns. © 25 ‘mfcrocuries of 131 fodine were given orally the day before for
autoradiographic studies of removed thyroid tissues. In surgery a firm area waa noted
MEDICATION:
Thyroid lobular hyperplasia and hypertrophy
with slight fibrosis.
—
Continued treatment with Lethyroxin (3 MG-
a
day) is recommended since he is part of
the more heavily exposed Rongelap group,
§
all of whom have been placed on such treatment
since 1965.
ep
Be
ar
Se
:
..
rigiee.
1G
oS
pepe
. ee
SEs
:
,
.
file? 2 Coome~
” oes i .
- 123 -
Robert A. Conard, M.D.
:
vm
i ed
7 F
a
ee
ade Mo
DIAGWOSTS: -~ *.
ote
Se:
"as
ore!
the
also several areas of nodularity were noted in isthmus. The lower part of the isthmus
and part of the right lobe were removed. The pathologist reported the lesions benign
with.varying degrees of hyperthrophy, hyperplasia and fibrosis. The patient withstood
the surgery well and his convalescence was uneventful. He was discharged on June 18th
to return to Che Marshall Islands. Copies of the Hospital Summary and Pathological
Reports. from Cleveland incorporated with the BNL records.
FT,
Oy
wee,
-
at the junction of the right lobe and isthmus which contained several small nodules and